BECN1 and hepatocellular carcinoma: The level of Beclin-1 in lenvatinib-resistant HCC patients was significantly higher than that in lenvatinib-sensitive patients (Fig. 4F), whereas the trends of p62 level was reverse (Fig. 4G).